Suppr超能文献

腹膜透析患者的膜补体调节因子改变与转运蛋白状态相关。

Alteration of membrane complement regulators is associated with transporter status in patients on peritoneal dialysis.

作者信息

Kitterer Daniel, Biegger Dagmar, Segerer Stephan, Braun Niko, Alscher M Dominik, Latus Joerg

机构信息

Department of Internal Medicine, Division of Nephrology, Robert-Bosch-Hospital, Stuttgart, Germany.

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, University of Tuebingen, Stuttgart, Germany.

出版信息

PLoS One. 2017 May 19;12(5):e0177487. doi: 10.1371/journal.pone.0177487. eCollection 2017.

Abstract

INTRODUCTION

A growing body of evidence from animal models and cell culture studies indicate an important role of a local regulatory complement system (CS) in peritoneal injury during peritoneal dialysis (PD). We investigated the expression of the local regulatory CS (reflected by CD46,CD55,CD59) in the peritoneal tissue of patients with different membrane function characteristics.

PATIENTS AND METHODS

Biopsies from the parietal peritoneum were taken from 24 patients on PD, 22 uremic patients prior to PD. PD patients were grouped according to the dialysate-to-plasma ratio of creatinine (D/P Cre) and ratio of dialysate glucose at 4 hours versus dialysate glucose at time zero (D/D0 glucose) into low or low-average peritoneal transport status (L/LA) and high-average or high-transport status (HA/H) groups. CD46, CD55, and CD59 RNA expression were analyzed by real-time polymerase chain reaction (RT-PCR). Further localization of membrane complement regulators (CRegs) and semiquantitatively analysis was done by immunohistochemistry (IHC).

RESULTS

CD46 and CD59 expression were similar in all groups. CD55 expression was significantly decreased in the HA/H group compared to the L/LA group and to uremic controls (p < 0.05 and p = 0.05, respectively). No statistically significant differences in CD46, CD55, and CD55 expression were detected when considering the history of peritonitis. There was no statistically significant correlation between PD duration and the expressions of CD46, CD55, and CD59. IHC revealed strong CD46, CD55, and CD59 expression in mesothelial cells. CD55 and CD59 were additionally detected in the vasculature. Using IHC, CD46 was lower in PD patients compared to uremic controls (p>0.05), but there was no difference between the L/LA compared to the H/HA group. Moreover IHC confirmed decreased expression of CD55 in the HA/H group compared to the L/LA group and uremic controls (p<0.0001 and p = 0.0001, respectively).

CONCLUSION

CD55 expression is decreased in patients with fast transporter membrane function, whereas peritonitis and PD duration do not appear to alter CReg expression.

摘要

引言

来自动物模型和细胞培养研究的越来越多的证据表明,局部调节性补体系统(CS)在腹膜透析(PD)期间的腹膜损伤中起重要作用。我们研究了具有不同膜功能特征的患者腹膜组织中局部调节性CS(以CD46、CD55、CD59为代表)的表达情况。

患者与方法

从24例接受PD治疗的患者、22例PD治疗前的尿毒症患者的壁层腹膜获取活检组织。PD患者根据肌酐的透析液与血浆比值(D/P Cre)以及4小时透析液葡萄糖与零时刻透析液葡萄糖的比值(D/D0葡萄糖)分为低或低平均腹膜转运状态(L/LA)组和高平均或高转运状态(HA/H)组。通过实时聚合酶链反应(RT-PCR)分析CD46、CD55和CD59的RNA表达。通过免疫组织化学(IHC)对膜补体调节因子(CRegs)进行进一步定位并进行半定量分析。

结果

所有组中CD46和CD59的表达相似。与L/LA组和尿毒症对照组相比,HA/H组中CD55的表达显著降低(分别为p < 0.05和p = 0.05)。考虑腹膜炎病史时,未检测到CD46、CD55和CD55表达的统计学显著差异。PD持续时间与CD46、CD55和CD59的表达之间无统计学显著相关性。IHC显示间皮细胞中CD46、CD55和CD59表达强烈。在脉管系统中还检测到CD55和CD59。使用IHC,与尿毒症对照组相比,PD患者中CD46较低(p>0.05),但L/LA组与H/HA组之间无差异。此外,IHC证实与L/LA组和尿毒症对照组相比,HA/H组中CD55的表达降低(分别为p<0.0001和p = 0.0001)。

结论

快速转运体膜功能患者中CD55表达降低,而腹膜炎和PD持续时间似乎不会改变CReg表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9fa3/5438122/126f50d03afc/pone.0177487.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验